Abstract:e12028 Background: Continuous exposure of breast cancer cells to adriamycin (ADR) induces the over-expression of P-glycoprotein (P-gp) and multiple drug resistance. However, the biochemical process and underlying mechanisms are not clear. Our previous study revealed that ADR increased reactive oxygen species (ROS) generation and reduced glutathione (GSH) biosynthesis, while N-acetylcysteine, the ROS scavenger, reversed the over-expressed P-gp induced by ADR. Methods: Based on MCF-7 breast cancer cells and the adriamycin-resistant MCF-7 subline (MCF-7R), we investigated the P-gp expression on mRNA, protein and function level by qPCR, western blotting, flow cytometry and laser scanning confocal and so on, under SLC7A11 down-regulation/over-expression, cystine depletion/supplement, increased ROS generation and combined factors. Results: The present study showed that ADR inhibited cystine influx (source material of GSH) and SLC7A11 transporter (in charge of cystine uptake) in MCF-7 cells. For the first time, we showed that a down-regulation/silence of SLC7A11, or cystine deprivation, or an enhanced exposure of ROS agents directly and significantly increased P-gp expression; yet, a combination of either an inhibited/silenced SLC7A11 or cystine deprivation and an increased ROS dramatically promoted the P-gp expression in MCF-7 cells. On the contrary, an over-expression of SLC7A11, or sufficiently supplementary cystine, or scavenger of ROS significantly depressed P-gp expression and activity. Moreover, the down-regulation of SLC7A11 and cystine deprivation induced an elevation of ROS and P-gp that could be reversed by N-acetylcysteine. It was suggested that ROS and SLC7A11/cystine were the two relevant factors responsible for the upregulated expression and function of P-gp. Conclusions: This study provided the direct evidences suggesting that ROS triggered over-expression of P-gp and demonstrated that the combination of either an inhibition of SLC7A11 or cystine influx and elevated ROS was the underlying mechanism contributing to P-gp over-expression induced by ADR. It was indicated that the SLC7A11 might be a potential target modulating ADR resistance.

PLAC8 Promotes Adriamycin Resistance Via Blocking Autophagy in Breast Cancer

PLCA8 Suppresses Breast Cancer Apoptosis by Activating the PI3k/AKT/NF‐κB Pathway

PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway

Modification of PLAC8 by UFM1 Affects Tumorous Proliferation and Immune Response by Impacting PD-L1 Levels in Triple-Negative Breast Cancer.

Multifaced roles of PLAC8 in cancer

The Novel KLF4/PLAC8 Signaling Pathway Regulates Lung Cancer Growth.

Abstract 2988: PLAC8 Confers the Chemoresistance of Placental Site Trophoblastic Tumor and Choriocarcinoma to Etoposide in an Autophagy-Dependent Manner

PLAC8 Overexpression Correlates with PD-L1 Upregulation and Acquired Resistance to Chemotherapies in Gallbladder Carcinoma.

PLAC8 Inhibits Oral Squamous Cell Carcinogenesis and Epithelial-Mesenchymal Transition Via the Wnt/β-catenin and PI3K/Akt/GSK3β Signaling Pathways

Plac8‐mediated Autophagy Regulates Nasopharyngeal Carcinoma Cell Function Via AKT/mTOR Pathway

Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma

Glutathione S-transferases P1 Protects Breast Cancer Cell from Adriamycin-Induced Cell Death Through Promoting Autophagy

Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy.

Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers

Compound 968 Reverses Adriamycin Resistance in Breast Cancer MCF-7ADR Cells Via Inhibiting P-glycoprotein Function Independently of Glutaminase.

Autophagy Facilitates Lung Adenocarcinoma Resistance to Cisplatin Treatment by Activation of AMPK/mTOR Signaling Pathway.

The Underlying Mechanism Contributing to P-gp Over-Expression and Drug Resistance in the MCF-7 Breast Cancer Cells Induced by Adriamycin.

Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells

Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis

TSPAN8 + Myofibroblastic Cancer–associated Fibroblasts Promote Chemoresistance in Patients with Breast Cancer

PLAC8 Contributes to the Malignant Behaviors of Cervical Cancer Cells by Activating the SOX4-mediated AKT Pathway